From Patient Centricity to Patient Partnership: Rethinking How Clinical Trials Are Designed

Recruitment challenges can begin long before a clinical trial opens for enrollment. Protocol complexity, restrictive eligibility criteria, and the demands of participation can all shape who is able and willing to take part.

This executive summary captures perspectives from an exclusive panel discussion, hosted by Citeline in partnership with EmVenio, bringing together voices from clinical research, drug development, academia, and patient advocacy.

In this executive summary, explore:

How patient input can inform study outcomes, procedures, and participation requirements.
Why protocol complexity and eligibility criteria can create barriers to access.
How to determine which trial activities require a research site and which could take place closer to patients.
Why patient-focused investments need to be considered across the study timeline.
What it takes to make patient partnership part of clinical development.

Fill out the form to
access the Executive Summary

Work Email Address

First name

Last name

Company

Job Title

State or Province

Business Phone

Industry

Function

Role

Country

You agree Citeline and EmVenio may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Citeline and EmVenio.

From Patient Centricity to Patient Partnership: Rethinking How Clinical Trials Are Designed

Fill out the form toaccess the Executive Summary

Fill out the form to
access the Executive Summary